Regression of Triple-Negative Breast Cancer in a Patient-Derived Xenograft Mouse Model by Monoclonal Antibodies against IL-12 p40 Monomer.

Regression of Triple-Negative Breast Cancer in a Patient-Derived Xenograft Mouse Model by Monoclonal Antibodies against IL-12 p40 Monomer. Cells. 2022 01 13; 11(2).

View in: PubMed

subject areas

Adaptive Immunity
Animals
Antibodies, Monoclonal
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Female
Humans
Immunotherapy
Interferon-gamma
Interleukin-12
Interleukin-12 Subunit p40
Interleukin-23
Macrophages
Mice, Inbred NOD
Mice, SCID
Neutralization Tests
Spleen
Triple Negative Breast Neoplasms
Up-Regulation
Xenograft Model Antitumor Assays

authors with profiles

Kalipada Pahan